vs

Side-by-side financial comparison of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) and Marti Technologies, Inc. (MRT). Click either name above to swap in a different company.

KESTRA MEDICAL TECHNOLOGIES, LTD. is the larger business by last-quarter revenue ($22.6M vs $14.6M, roughly 1.6× Marti Technologies, Inc.).

Kestra Medical Technologies, Ltd. is a medical device firm that develops, manufactures and commercializes innovative minimally invasive therapeutic solutions, mainly for interventional cardiology and structural heart disease treatment. It operates across North America, Europe and key Asia-Pacific markets, serving global healthcare providers and patients.

The Marti Group is a Swiss construction company, consisting of over 80 subsidiaries, officially owned by Marti Holding AG. Besides Switzerland, they are active in neighboring countries such as Germany and Austria, and also outside of Europe such as China and Chile. The company is known for high-profile public and private sector projects and using innovative technologies. Their areas of expertise include building construction, construction and renovation of tunnels, road construction, hydrauli...

KMTS vs MRT — Head-to-Head

Bigger by revenue
KMTS
KMTS
1.6× larger
KMTS
$22.6M
$14.6M
MRT

Income Statement — Q2 FY2026 vs Q2 FY2025

Metric
KMTS
KMTS
MRT
MRT
Revenue
$22.6M
$14.6M
Net Profit
$-32.8M
Gross Margin
50.6%
49.4%
Operating Margin
-140.7%
-86.1%
Net Margin
-145.3%
Revenue YoY
63.1%
Net Profit YoY
EPS (diluted)
$-0.64
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KMTS
KMTS
MRT
MRT
Q4 25
$22.6M
Q3 25
$19.4M
Q2 25
$14.6M
Q2 24
$8.9M
Net Profit
KMTS
KMTS
MRT
MRT
Q4 25
$-32.8M
Q3 25
$-25.8M
Q2 25
Q2 24
Gross Margin
KMTS
KMTS
MRT
MRT
Q4 25
50.6%
Q3 25
45.7%
Q2 25
49.4%
Q2 24
Operating Margin
KMTS
KMTS
MRT
MRT
Q4 25
-140.7%
Q3 25
-149.1%
Q2 25
-86.1%
Q2 24
-204.1%
Net Margin
KMTS
KMTS
MRT
MRT
Q4 25
-145.3%
Q3 25
-133.3%
Q2 25
Q2 24
EPS (diluted)
KMTS
KMTS
MRT
MRT
Q4 25
$-0.64
Q3 25
$-0.50
Q2 25
$-0.26
Q2 24
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KMTS
KMTS
MRT
MRT
Cash + ST InvestmentsLiquidity on hand
$175.4M
$4.2M
Total DebtLower is stronger
$83.0M
Stockholders' EquityBook value
$164.1M
$-73.2M
Total Assets
$246.7M
$17.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KMTS
KMTS
MRT
MRT
Q4 25
$175.4M
Q3 25
$201.2M
Q2 25
$4.2M
Q2 24
$9.0M
Total Debt
KMTS
KMTS
MRT
MRT
Q4 25
Q3 25
Q2 25
$83.0M
Q2 24
$60.2M
Stockholders' Equity
KMTS
KMTS
MRT
MRT
Q4 25
$164.1M
Q3 25
$184.2M
Q2 25
$-73.2M
Q2 24
$-51.2M
Total Assets
KMTS
KMTS
MRT
MRT
Q4 25
$246.7M
Q3 25
$266.3M
Q2 25
$17.2M
Q2 24
$25.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KMTS
KMTS
MRT
MRT
Operating Cash FlowLast quarter
$-18.3M
Free Cash FlowOCF − Capex
$-25.6M
FCF MarginFCF / Revenue
-113.5%
Capex IntensityCapex / Revenue
32.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KMTS
KMTS
MRT
MRT
Q4 25
$-18.3M
Q3 25
$-26.3M
Q2 25
Q2 24
Free Cash Flow
KMTS
KMTS
MRT
MRT
Q4 25
$-25.6M
Q3 25
$-34.4M
Q2 25
Q2 24
FCF Margin
KMTS
KMTS
MRT
MRT
Q4 25
-113.5%
Q3 25
-177.8%
Q2 25
Q2 24
Capex Intensity
KMTS
KMTS
MRT
MRT
Q4 25
32.2%
Q3 25
42.2%
Q2 25
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons